Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Peter Nählstedt. CEO, SenzaGen
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
SenzaGen's CEO Peter Nählstedt presents the company
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Global RV Tourism Expansion: Strategic Growth and Financial Stability|Grant Webster,Chief Executive Officer, Tourism Holdings Limited (THL)
00:10:00
Fiona Dawson on Embracing a Dynamic Mining Career and Promoting Diversity at Newmont
00:10:00
Glenn Harold Honored with Legends of Steel Award
00:10:00
Monica Pedroza: Inspired Pro Bono Work at Morgan Lewis | MONICA C. PEDROZA - ASSOCIATE of Morgan, Lewis & Bockius LLP
00:10:00
125M Fund Managing Director on How to Build Consumer Brands|Karen Howland,General Partner,CircleUp
00:10:00
Todd Schoenberger Joins J. Striker Asset Management as President
00:10:00
Unlocking the Potential of Employee Stock Options | Robbie Scoonmaker, CFP, Matterhorn Financial Planning
00:10:00
Impact of Climate Change on Your Investments: Insights from AIO Financial | Bill Holliday - Certified Financial Planner (CFP) of AIO Financial, LLC
00:10:00
Real experience signing a new deal with a major international computing firm | Dave Page, CEO, Actual Experience PLCACT:LSE
00:10:00
Science Applications International Corp. CEO Toni Townes-Whitley discusses the latest earnings report and integrating new technologies.
00:10:00
AnalytixInsight Inc. (TSX-V: ALY) (OTCQB: ATIXF) | Chaith Kondragunta, CEO, AnalytixInsight IncALY:CVE
00:10:00
CEO Andreas Thorsheim presents Otovo, a Norwegian startup offering a residential solar and battery marketplace, at Ecosummit Berlin 2023.